(TEAM) Atlassian - Overview
Sector: Technology | Industry: Software - Application | Exchange: NASDAQ (USA) | Market Cap: 21.677m USD | Total Return: -59.8% in 12m
Avg Turnover: 541M
EPS Trend: 6.7%
Qual. Beats: 1
Rev. Trend: 99.9%
Qual. Beats: 3
Warnings
Interest Coverage Ratio -3.5 is critical
Altman Z'' -6.03 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
Confidence
Atlassian Corporation (TEAM) is a global software provider specializing in team collaboration and project management tools. Its core product suite includes Jira for workflow tracking, Confluence for document sharing, and Trello for personal productivity. The company operates a high-velocity, low-touch sales model that relies on word-of-mouth adoption and a vast marketplace of third-party integrations rather than a traditional direct sales force.
The company has recently expanded its portfolio into AI-driven capabilities through Rovo and asynchronous video via the acquisition of Loom. As a major player in the Application Software sector, Atlassian focuses on the DevOps and ITSM (IT Service Management) markets, where high switching costs often lead to strong customer retention. For a deeper look into these fundamental drivers, consider reviewing the detailed metrics on ValueRay.
Headquartered in Australia, Atlassian also maintains strategic partnerships to serve high-security environments, such as its collaboration with Mattermost for self-hosted infrastructure. This approach allows the firm to capture diverse market segments ranging from small startups to large-scale enterprise defense organizations.
- Cloud migration of legacy on-premise customers stabilizes long-term subscription revenue growth
- Enterprise adoption of Jira Service Management expands total addressable market share
- Integration of Rovo AI features drives higher average revenue per user
- Operating margin expansion depends on disciplined research and development spending levels
- Corporate headcount reductions in technology sector dampen seat-based licensing demand
| Net Income: -216.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA -3.40 > 1.0 |
| NWC/Revenue: -15.98% < 20% (prev 15.81%; Δ -31.79% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.25b > Net Income -216.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (261.0m) vs 12m ago -0.65% < -2% |
| Gross Margin: 83.85% > 18% (prev 0.82%; Δ 8.30k% > 0.5%) |
| Asset Turnover: 107.3% > 50% (prev 84.34%; Δ 22.99% > 0%) |
| Interest Coverage Ratio: -3.49 > 6 (EBITDA TTM -27.2m / Interest Expense TTM 43.4m) |
| A: -0.18 (Total Current Assets 2.33b - Total Current Liabilities 3.32b) / Total Assets 5.65b |
| B: -1.04 (Retained Earnings -5.90b / Total Assets 5.65b) |
| C: -0.03 (EBIT TTM -151.6m / Avg Total Assets 5.77b) |
| D: -1.24 (Book Value of Equity -5.91b / Total Liabilities 4.77b) |
| Altman-Z'' = -6.03 = D |
| DSRI: 1.13 (Receivables 907.4m/642.0m, Revenue 6.19b/4.96b) |
| GMI: 0.98 (GM 83.85% / 82.31%) |
| AQI: 1.76 (AQ_t 0.55 / AQ_t-1 0.31) |
| SGI: 1.25 (Revenue 6.19b / 4.96b) |
| TATA: -0.26 (NI -216.8m - CFO 1.25b) / TA 5.65b) |
| Beneish M = -2.57 (Cap -4..+1) = A |
As of May 27, 2026, the stock is trading at USD 84.92 with a total of 4,012,340 shares traded.
Over the past week, the price has changed by -5.05%,
over one month by +22.68%,
over three months by +6.91% and
over the past year by -59.77%.
Atlassian has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy TEAM.
- StrongBuy: 19
- Buy: 7
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 143.2 | 68.6% |
P/E Forward = 13.0548
P/S = 3.5018
P/B = 24.66
P/EG = 0.6531
Revenue TTM = 6.19b USD
EBIT TTM = -151.6m USD
EBITDA TTM = -27.2m USD
Long Term Debt = 989.1m USD (from longTermDebt, last quarter)
Short Term Debt = 48.2m USD (from shortTermDebt, last quarter)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter) + Leases 253.9m
Net Debt = 360.6m USD (calculated: Debt 1.50b - CCE 1.14b)
Enterprise Value = 22.0b USD (21.7b + Debt 1.50b - CCE 1.14b)
Interest Coverage Ratio = -3.49 (Ebit TTM -151.6m / Interest Expense TTM 43.4m)
EV/FCF = 18.29x (Enterprise Value 22.0b / FCF TTM 1.20b)
FCF Yield = 5.47% (FCF TTM 1.20b / Enterprise Value 22.0b)
FCF Margin = 19.46% (FCF TTM 1.20b / Revenue TTM 6.19b)
Net Margin = -3.50% (Net Income TTM -216.8m / Revenue TTM 6.19b)
Gross Margin = 83.85% ((Revenue TTM 6.19b - Cost of Revenue TTM 999.5m) / Revenue TTM)
Gross Margin QoQ = 84.92% (prev 85.02%)
Tobins Q-Ratio = 3.90 (Enterprise Value 22.0b / Total Assets 5.65b)
Interest Expense / Debt = 2.90% (Interest Expense 43.4m / Debt 1.50b)
Taxrate = 21.0% (US default 21%)
NOPAT = -119.8m (EBIT -151.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.70 (Total Current Assets 2.33b / Total Current Liabilities 3.32b)
Debt / Equity = 1.70 (Debt 1.50b / totalStockholderEquity, last quarter 879.0m)
Debt / EBITDA = -13.26 (negative EBITDA) (Net Debt 360.6m / EBITDA -27.2m)
Debt / FCF = 0.30 (Net Debt 360.6m / FCF TTM 1.20b)
Total Stockholder Equity = 1.30b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.76% (Net Income -216.8m / Total Assets 5.65b)
RoE = -3.01% (Net Income TTM -216.8m / Total Stockholder Equity 7.19b)
RoCE = -1.85% (EBIT -151.6m / Capital Employed (Equity 7.19b + L.T.Debt 989.1m))
RoIC = -6.52% (negative operating profit) (NOPAT -119.8m / Invested Capital 1.84b)
WACC = 11.91% (E(21.7b)/V(23.2b) * Re(12.57%) + D(1.50b)/V(23.2b) * Rd(2.90%) * (1-Tc(0.21)))
Discount Rate = 12.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 53.55 | Cagr: 0.34%
[DCF] Terminal Value 61.07% ; FCFF base≈1.30b ; Y1≈1.14b ; Y5≈924.3m
[DCF] Fair Price = 56.61 (EV 9.40b - Net Debt 360.6m = Equity 9.04b / Shares 159.6m; r=11.91% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 6.70 | EPS CAGR: 3.36% | SUE: 2.43 | # QB: 1
Revenue Correlation: 99.86 | Revenue CAGR: 21.74% | SUE: 3.06 | # QB: 3
EPS next Quarter (2026-09-30): EPS=1.31 | Chg30d=+11.64% | Revisions=+66% | Analysts=26
EPS current Year (2026-06-30): EPS=5.50 | Chg30d=+15.78% | Revisions=+88% | GrowthEPS=+49.6% | GrowthRev=+24.0%
EPS next Year (2027-06-30): EPS=6.21 | Chg30d=+11.98% | Revisions=+88% | GrowthEPS=+12.8% | GrowthRev=+14.9%
[Analyst] Revisions Ratio: +88%